Howe & Rusling Inc. lessened its holdings in McKesson Co. (NYSE:MCK - Free Report) by 77.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,031 shares of the company's stock after selling 6,993 shares during the period. Howe & Rusling Inc.'s holdings in McKesson were worth $1,158,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in MCK. Millstone Evans Group LLC bought a new stake in shares of McKesson during the 4th quarter valued at $28,000. RPg Family Wealth Advisory LLC bought a new stake in McKesson during the third quarter valued at about $31,000. Synergy Asset Management LLC purchased a new stake in McKesson in the fourth quarter worth about $32,000. Crews Bank & Trust bought a new position in shares of McKesson in the fourth quarter worth about $33,000. Finally, Atala Financial Inc purchased a new position in shares of McKesson during the 4th quarter valued at about $34,000. 85.07% of the stock is currently owned by institutional investors.
Insider Buying and Selling at McKesson
In other McKesson news, EVP Leann B. Smith sold 579 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the sale, the executive vice president now owns 864 shares of the company's stock, valued at approximately $494,890.56. This trade represents a 40.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the transaction, the chief executive officer now owns 60,664 shares of the company's stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,689 shares of company stock valued at $11,187,351 in the last ninety days. Corporate insiders own 0.11% of the company's stock.
McKesson Trading Down 0.0 %
Shares of MCK stock traded down $0.25 during trading hours on Monday, reaching $667.81. 326,975 shares of the stock were exchanged, compared to its average volume of 815,493. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $678.67. The firm has a market capitalization of $83.69 billion, a price-to-earnings ratio of 30.58, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. The company's 50-day moving average price is $623.58 and its 200-day moving average price is $579.83.
McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, sell-side analysts expect that McKesson Co. will post 32.77 EPS for the current year.
McKesson Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be paid a $0.71 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.43%. McKesson's dividend payout ratio (DPR) is currently 13.00%.
Analysts Set New Price Targets
MCK has been the topic of a number of recent analyst reports. Morgan Stanley raised their target price on shares of McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Mizuho began coverage on shares of McKesson in a research report on Wednesday, December 4th. They set a "neutral" rating and a $630.00 price objective on the stock. Evercore ISI increased their price target on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research note on Thursday, February 6th. Bank of America lowered their price objective on McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, StockNews.com cut McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Two analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and an average price target of $649.36.
Check Out Our Latest Analysis on MCK
McKesson Profile
(
Free Report)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Stories
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
